Farnesoid X receptor agonist GW4064 indirectly inhibits HCV entry into cells via down-regulating scavenger receptor class B type I
Zhouyi Wu(Chinese Academy of Medical Sciences & Peking Union Medical College), Zong‐Gen Peng(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian‐Dong Jiang(Ningbo University), Hu Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianrui Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoqin Lv(Chongqing Medical University)
Cited by 13
Related Papers
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation
|Theranostics|2019|185
Loss of Epigenetic Control of <i>Synuclein-γ</i> Gene as a Molecular Indicator of Metastasis in a Wide Range of Human Cancers
|Cancer Research|2005|179
Extracellular Signal-Regulated Kinase–Dependent Stabilization of Hepatic Low-Density Lipoprotein Receptor mRNA by Herbal Medicine Berberine
|Arteriosclerosis Thrombosis and Vascular Biology|2005|171